Artia Global Partners’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding LYRA
Artia Global Partners's LYRA Position: Q1 2026 in Review
Artia Global Partners sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 8,756 shares — an estimated $27K sold.
Artia Global Partners first reported a position in LYRA in Q4 2025 and held it in 1 quarter. The position peaked at $27K in Q4 2025. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- Artia Global Partners reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Artia Global Partners sold 8,756 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $27K.
- Artia Global Partners first reported a position in LYRA THERAPEUTICS INC in Q4 2025 and held it in 1 quarter.
- Artia Global Partners's LYRA THERAPEUTICS INC position peaked at $27K in Q4 2025.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.